Document
IPR2021-00816, No. 114 Order Other - Order Dismissing Motion to Exclude as Moot 37 CFR secs 4264c, 4261a (P.T.A.B. Oct. 25, 2022)
Cite Document
IPR2021-00816, No. 114 Order Other - Order Dismissing Motion to Exclude as Moot 37 CFR secs 4264c, 4261a (P.T.A.B. Oct. 25, 2022)
+ More Snippets
Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 591 (D.Del. Oct. 25, 2022)
Cite Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 591 (D.Del. Oct. 25, 2022)
+ More Snippets
Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 589 (D.Del. Oct. 20, 2022)
Cite Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 589 (D.Del. Oct. 20, 2022)
+ More Snippets
Document
Certain Silica Coated Lead Chromate Pigments, 337-120, No. 782684-1 (U.S.I.T.C. Oct. 20, 2022)
Cite Document
Certain Silica Coated Lead Chromate Pigments, 337-120, No. 782684-1 (U.S.I.T.C. Oct. 20, 2022)
+ More Snippets
Document
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company, 1:18-cv-12029, No. 544 (D.Mass. Oct. 18, 2022)
Cite Document
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company, 1:18-cv-12029, No. 544 (D.Mass. Oct. 18, 2022)
+ More Snippets
Document
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company, 1:18-cv-12029, No. 531 (D.Mass. Oct. 17, 2022)
Cite Document
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company, 1:18-cv-12029, No. 531 (D.Mass. Oct. 17, 2022)
+ More Snippets
Document
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company, 1:18-cv-12029, No. 535 (D.Mass. Oct. 17, 2022)
Cite Document
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company, 1:18-cv-12029, No. 535 (D.Mass. Oct. 17, 2022)
+ More Snippets
Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 587 (D.Del. Oct. 17, 2022)
Cite Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 587 (D.Del. Oct. 17, 2022)
+ More Snippets
Document
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company, 1:18-cv-12029, No. 528 (D.Mass. Oct. 14, 2022)
Cite Document
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company, 1:18-cv-12029, No. 528 (D.Mass. Oct. 14, 2022)
+ More Snippets
Document
OssiFi-Mab LLC v. Amgen Inc., 1:23-cv-10861, No. 142 (D.Mass. Nov. 25, 2024)
Cite Document
OssiFi-Mab LLC v. Amgen Inc., 1:23-cv-10861, No. 142 (D.Mass. Nov. 25, 2024)
+ More Snippets
Document
OssiFi-Mab LLC v. Amgen Inc., 1:23-cv-10861, No. 143 (D.Mass. Nov. 25, 2024)
Cite Document
OssiFi-Mab LLC v. Amgen Inc., 1:23-cv-10861, No. 143 (D.Mass. Nov. 25, 2024)
+ More Snippets
Document
OssiFi-Mab LLC v. Amgen Inc., 1:23-cv-10861, No. 144 (D.Mass. Nov. 25, 2024)
Cite Document
OssiFi-Mab LLC v. Amgen Inc., 1:23-cv-10861, No. 144 (D.Mass. Nov. 25, 2024)
+ More Snippets
Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 584 (D.Del. Oct. 11, 2022)
Cite Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 584 (D.Del. Oct. 11, 2022)
+ More Snippets
Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 585 (D.Del. Oct. 11, 2022)
Cite Document
In re: Palbociclib Patent Litigation, 1:19-md-02912, No. 585 (D.Del. Oct. 11, 2022)
+ More Snippets
Document
OssiFi-Mab LLC v. Amgen Inc., 1:23-cv-10861, No. 87 (D.Mass. Mar. 13, 2024)
Cite Document
OssiFi-Mab LLC v. Amgen Inc., 1:23-cv-10861, No. 87 (D.Mass. Mar. 13, 2024)
+ More Snippets